GB202103762D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB202103762D0
GB202103762D0 GBGB2103762.7A GB202103762A GB202103762D0 GB 202103762 D0 GB202103762 D0 GB 202103762D0 GB 202103762 A GB202103762 A GB 202103762A GB 202103762 D0 GB202103762 D0 GB 202103762D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2103762.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Priority to GBGB2103762.7A priority Critical patent/GB202103762D0/en
Publication of GB202103762D0 publication Critical patent/GB202103762D0/en
Ceased legal-status Critical Current

Links

GBGB2103762.7A 2021-03-18 2021-03-18 Formulations Ceased GB202103762D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2103762.7A GB202103762D0 (en) 2021-03-18 2021-03-18 Formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2103762.7A GB202103762D0 (en) 2021-03-18 2021-03-18 Formulations

Publications (1)

Publication Number Publication Date
GB202103762D0 true GB202103762D0 (en) 2021-05-05

Family

ID=75689795

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2103762.7A Ceased GB202103762D0 (en) 2021-03-18 2021-03-18 Formulations

Country Status (1)

Country Link
GB (1) GB202103762D0 (en)

Similar Documents

Publication Publication Date Title
IL287224A (en) Novel formulations comprising melflufen
GB201904338D0 (en) Fluorouracil-containing formulations
PT4045038T (en) New formulations
GB202007546D0 (en) Formulation
GB202018889D0 (en) Formulations
IL290356A (en) Larazotide formulations
GB202009684D0 (en) Formulations
IL284691A (en) Formulations
IL312207A (en) Formulations
IL312211A (en) Formulations
GB202103780D0 (en) Formulations
GB202103762D0 (en) Formulations
GB202103785D0 (en) Formulations
GB202018251D0 (en) Formulations
GB202018250D0 (en) Formulations
GB202009685D0 (en) Formulations
GB202117828D0 (en) New formulations
GB202108259D0 (en) Novel formulations
GB202004811D0 (en) Novel Formulations
GB202004814D0 (en) Novel formulations
GB202315863D0 (en) Formulations
GB202307059D0 (en) Formulations
GB202216961D0 (en) 5-meo-mt formulations
GB201911063D0 (en) Formulations
GB201905105D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)